Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAUNORUBICIN vs DEFERASIROX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAUNORUBICIN vs DEFERASIROX: Safety Overview

Metric DAUNORUBICIN DEFERASIROX
Total FAERS Reports 9,852 11,322
Deaths Reported 2,263 2,661
Death Rate 23.0% 23.5%
Hospitalizations 4,248 4,008
Average Patient Age 28.7 yrs 49.8 yrs
% Female Patients 46.4% 50.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 11, 2025
Manufacturer Hikma Pharmaceuticals USA Inc. AvKARE
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription